TRMED Share Price Performance
NOK 4.51
2.03 (82.39%)
28.7% overvalued intrinsic discount
NOK 3.50
Fair Value
Price NOK 4.51
AnalystConsensusTarget NOK 3.50
Fair ValueNOK 3.50
Share Pricen/a
Thor Medical ASA Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
TRMED Community Narratives
AN
Fair Value NOK 3.5 28.7% overvalued intrinsic discount
Alpha Emitter Capacity Ramp And Order Backlog Will Eventually Undermine This Bullish Narrative
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Alpha Emitter Capacity Ramp And Order Backlog Will Eventually Undermine This Bullish Narrative
Catalysts About Thor Medical Thor Medical focuses on producing alpha emitting isotopes for radiopharmaceutical companies using a proprietary thorium based process. What are the underlying business or industry changes driving this perspective?Read more
21
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
NOK 3.5
28.7% overvalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
1.11k% p.a.
Profit Margin
15.44%
Future PE
54.41x
Price in 2029
NOK 4.24
Trending Discussion
Recently Updated Narratives
AN
Alpha Emitter Capacity Ramp And Order Backlog Will Eventually Undermine This Bullish Narrative
Fair Value: NOK 3.5 28.7% overvalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Thor Medical ASA Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 26, 2026
- -0.17
- 100.00%
- -58,908.00%
- 0%
About TRMED
- Founded
- 2009
- Employees
- 13
- CEO
- WebsiteView website
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
